Akers Biosciences Inc (AKER) - Product Pipeline Analysis, 2019 Update

Summary

Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA chlamydia, PIFA dengue fever, PIFA malaria, PIFA syphilis, PIFA heparin, and breath ketone. ABI provides testing platform technologies, which include micro particle catalyzed biosensor, particle immune-filtration assay, rapid enzymatic assay, rapid blood cell separation, and synthetic macrocycle complex. The company serves medical clinicians, individuals, corporations, and law enforcement agencies, health professionals. ABI is headquartered in West Deptford, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Akers Biosciences Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company


List of Tables
List of Figures
Akers Biosciences Inc Company Overview
Akers Biosciences Inc Company Snapshot
Akers Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview
Akers Biosciences Inc Pipeline Analysis Overview
Akers Biosciences Inc - Key Facts
Akers Biosciences Inc - Major Products and Services
Akers Biosciences Inc Pipeline Products by Development Stage
Akers Biosciences Inc Pipeline Products Overview
Breath PulmoHealth Check - Asthma
Breath PulmoHealth Check - Asthma Product Overview
Breath PulmoHealth Check - COPD
Breath PulmoHealth Check - COPD Product Overview
Breath PulmoHealth Check - Lung Cancer
Breath PulmoHealth Check - Lung Cancer Product Overview
BreathScan Asthma
BreathScan Asthma Product Overview
BreathScan DKA
BreathScan DKA Product Overview
BreathScan THC
BreathScan THC Product Overview
Diagnostic Test - Heart Attack
Diagnostic Test - Heart Attack Product Overview
Handheld Electronic Reader
Handheld Electronic Reader Product Overview
minDNAnalyzer
minDNAnalyzer Product Overview
PIFA Chlamydia Rapid Assay
PIFA Chlamydia Rapid Assay Product Overview
PIFA Hep B / Hep C
PIFA Hep B / Hep C Product Overview
PIFA HIV 1+2 Rapid Assay
PIFA HIV 1+2 Rapid Assay Product Overview
PIFA PLUSS - Troponin I
PIFA PLUSS - Troponin I Product Overview
PIFA PLUSS Malaria Rapid Assay
PIFA PLUSS Malaria Rapid Assay Product Overview
Akers Biosciences Inc - Key Competitors
Akers Biosciences Inc - Key Employees
Akers Biosciences Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Recent Developments
Akers Biosciences Inc, Recent Developments
May 20, 2019: Akers Biosciences reports Q1 2019 earnings
Apr 01, 2019: Akers Biosciences reports fiscal year 2018 earnings
Feb 05, 2019: Akers Biosciences: Further Re. Directorate change
Nov 15, 2018: Akers Biosciences announces Q3 2018 earnings
Nov 15, 2018: Akers Biosciences announces financial results for the three months and nine months ended September 30, 2018
Oct 19, 2018: Akers Biosciences has announced the directorate change
Oct 08, 2018: Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
Sep 13, 2018: Akers Biosciences: Directorate change - form 8-K filing
Aug 14, 2018: Akers Biosciences announces Q2 and H1 2018 earnings
Jul 18, 2018: Akers biosciences signs a further independent sales representative organization for Heparin PF4 Rapid Test covering additional 12 states
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

List of Tables
Akers Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview
Akers Biosciences Inc Pipeline Products by Equipment Type
Akers Biosciences Inc Pipeline Products by Indication
Akers Biosciences Inc, Key Facts
Akers Biosciences Inc, Major Products and Services
Akers Biosciences Inc Number of Pipeline Products by Development Stage
Akers Biosciences Inc Pipeline Products Summary by Development Stage
Breath PulmoHealth Check - Asthma - Product Status
Breath PulmoHealth Check - Asthma - Product Description
Breath PulmoHealth Check - COPD - Product Status
Breath PulmoHealth Check - COPD - Product Description
Breath PulmoHealth Check - Lung Cancer - Product Status
Breath PulmoHealth Check - Lung Cancer - Product Description
BreathScan Asthma - Product Status
BreathScan Asthma - Product Description
BreathScan DKA - Product Status
BreathScan DKA - Product Description
BreathScan THC - Product Status
BreathScan THC - Product Description
Diagnostic Test - Heart Attack - Product Status
Diagnostic Test - Heart Attack - Product Description
Handheld Electronic Reader - Product Status
Handheld Electronic Reader - Product Description
minDNAnalyzer - Product Status
minDNAnalyzer - Product Description
PIFA Chlamydia Rapid Assay - Product Status
PIFA Chlamydia Rapid Assay - Product Description
PIFA Hep B / Hep C - Product Status
PIFA Hep B / Hep C - Product Description
PIFA HIV 1+2 Rapid Assay - Product Status
PIFA HIV 1+2 Rapid Assay - Product Description
PIFA PLUSS - Troponin I - Product Status
PIFA PLUSS - Troponin I - Product Description
PIFA PLUSS Malaria Rapid Assay - Product Status
PIFA PLUSS Malaria Rapid Assay - Product Description
Akers Biosciences Inc, Key Employees
Akers Biosciences Inc, Subsidiaries
Akers Biosciences Inc, Joint Venture
Glossary

List Of Figures

List of Figures
Akers Biosciences Inc Pipeline Products by Equipment Type
Akers Biosciences Inc Pipeline Products by Development Stage

Akers Biosciences Inc (AKER) - Product Pipeline Analysis, 2019 Update

Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its

USD 750 View Report

Global MRI Compatible Pacemakers Market Research Report 2019-2023

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. MRI Compatible Pacemakers Report by Material, Application, and

USD 2850 View Report

Angle Biosciences Inc - Product Pipeline Analysis, 2019 Update

Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors,

USD 750 View Report

Flagship Biosciences Inc - Medical Equipment - Deals and Alliances Profile

Flagship Biosciences Inc (Flagship Biosciences) is a drug development company that provides proprietary tissue analysis technology. The company provides precision medicine by quantifying and simplifying complex pathology. It has quantitative

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available